Trial intelligence / Profile preview

CORAL study of live-attenuated E. coli challenge

NCT02541695Completed

Sponsor
NIZO Food Research
Start
Sep 2015
Primary completion
Mar 2016
Countries
1
01

Overview

Randomised, open-label trial of escherichia coli strain E1392/75-2A in diarrhea, gastroenteritis and Escherichia coli infection (2 arms), sponsored by NIZO Food Research. Primary endpoint: Percentage of faecal dry weight. Started Sep 2015; status: completed.

02

Drugs

escherichia coli strain E1392/75-2A
03

Conditions

diarrheagastroenteritisEscherichia coli infection

Beyond the preview

Go deeper on NCT02541695.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02541695.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call